NFKB1 and arthritic joint disease: Qian et al. has demonstrated that kirenol could inhibit NF-κB activity by upregulating nuclear annexin-1 which interacted with NF-κB, and then reduced cytokines expression and thereby attenuated synovial inflammation of collagen-induced arthritis [19].